Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels

In heart failure patients, beta-blockade may lower IL-6 but not TNFα levels. Changes of IL-6 during beta-blockade may be related to changes of LV function and geometry.